Adicet Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $152,038,000.

Profit Margin

Adicet Bio, Inc. (LSE:0HX7.L): Profit margin
2017 0 -33.77M
2018 8.18M -9.29M -113.67%
2019 995K -28.13M -2827.94%
2020 17.90M -36.67M -204.87%
2021 9.73M -61.99M -637.19%
2022 24.99M -69.79M -279.27%
2023 0 -142.65M

0HX7.L Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
024.99M9.73M17.90M995K8.18M0
Cost of revenue
6.09M5.00M00125K05K
Gross profit
-6.09M19.98M9.73M17.90M870K8.18M-5K
Operating exp.
Research and development
106.04M71.24M48.94M34.33M23.69M14.71M16.83M
Selling and marketing
0-5.00M-4.06M-1.95M-1.23M00
Total operating expenses
152.03M92.53M67.09M48.04M31.14M18.61M18.87M
Operating income
-152.03M-72.55M-61.43M-32.09M-31.38M-14.96M-18.88M
Other income (expenses), net
9.38M2.76M-691K-302K3.26M5.07M-14.89M
Income before tax
-142.65M-69.79M-62.12M-39.49M-28.11M-9.88M-33.77M
Income tax expense
00-125K-2.81M19K589K0
Net income
-142.65M-69.79M-61.99M-36.67M-28.13M-9.29M-33.77M
Earnings per share
Basic EPS
-3.31-1.7-2-5.01-13.15-4.78-58.97
Diluted EPS
-3.31-1.7-2-5.01-13.15-4.78-58.97
Data sourceData sourceData sourceData sourceData sourceData sourceData source